| Bioactivity | Filapixant is a purinoreceptor antagonist extracted from patent WO2016091776A1, example 348. Filapixant is the active reference substance of Eliapixant[1]. | |||||||||
| Target | purinoreceptor | |||||||||
| Name | Filapixant | |||||||||
| CAS | 1948232-63-0 | |||||||||
| Formula | C24H26F3N5O3S | |||||||||
| Molar Mass | 521.56 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Davenport AJ, et, al. 1,3-thiazol-2-yl substituted benzamides. WO2016091776A1. |
Filapixant
CAS: 1948232-63-0 F: C24H26F3N5O3S W: 521.56
Filapixant is a purinoreceptor antagonist extracted from patent WO2016091776A1, example 348. Filapixant is the active re
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.